Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
Author(s) -
Franco Locatelli,
Michael B. Jordan,
Carl E. Allen,
Simone Cesaro,
Carmelo Rizzari,
Anupama Rao,
Barbara Degar,
Timothy P. Garrington,
Julián Sevilla,
M C Putti,
Franca Fagioli,
Martina Ahlmann,
José Luís Dapena,
M M Henry,
Fabrizio De Benedetti,
Alexei A. Grom,
G Lapeyre,
Philippe Jacqmin,
Maria Ballabio,
Cristina de Min
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1911326
Subject(s) - hemophagocytic lymphohistiocytosis , primary (astronomy) , medicine , pediatrics , physics , disease , astronomy
Primary hemophagocytic lymphohistiocytosis is a rare syndrome characterized by immune dysregulation and hyperinflammation. It typically manifests in infancy and is associated with high mortality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom